All 1 tracked stories fall under one category: health-it. MindMaze Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Tej Tadi
All 1 tracked stories fall under one category: health-it. MindMaze Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.3 for the same window. Their average consequence score of 5 runs below the beat's 5.9 for that window. We currently track 1 Healthcare story that mention Tej Tadi, all published on March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Tej Tadi. Shared-story counts are live from our verified record — not editorial picks.
MindMaze Therapeutics has appointed healthtech veteran Zach Henderson as its new CEO, signaling a pivot from research-heavy development to aggressive global commercialization. Henderson will lead the digital neurotherapeutics unicorn as it seeks to scale its VR-based brain repair platforms across international healthcare systems.